Modifications of the Covid-19 vaccine
Sign up for myFT Daily Digest to be the first to know about Covid-19 vaccine issues.
The Food and Drug Administration has approved a third BioNTech / Pfizer shot Covid-19 vaccine for Americans at risk including the age of 65 years and engaging in risky occupations such as medical care.
The idea of banning a third shot is a major problem for the US government in terms of a work of encouragement to many and comes after the FDA advisory committee last week voted unanimously as opposed to a patent For all persons over the age of 16.
The third drug will be given to all people over the age of 65 and between the ages of 18 and 64 who are at risk of Covid or who work in high-risk areas for coronavirus infection.
Advice is approved for six months after complete immunization.
“Today’s developments show that science and current data continue to guide the FDA’s decision to develop the Covid-19 vaccine at this time. plague, ”Said Janet Woodcock, FDA executive director.
He added that helpers could be found for “other people such as health workers, teachers and day care workers, food vendors and those in homeless shelters or prisons, among others”.
Last week the council’s advisers questioned the need for all 16-year-olds to be placed in a third-degree cohort for the risk of other cardiovascular complications, especially among adolescents.
Pfizer has emphasized the need for additional supplements, saying vaccination use decreases over time and Biden’s management has set September 20 as the recommended date.
Washington’s participation in pre-legal times has been criticized by some scientists and led to retirement of two top FDA members earlier this month.
“We believe that promoters have a key role to play in addressing the risk of the disease, including efforts to increase global access by people who are not vaccinated,” said Albert Bourla, Pfizer’s chief executive.
“Today the work of the FDA is an important part of helping those at risk among us to be safe in Covid-19,” he added.
The FDA’s proposal came after Joe Biden’s vaccination meeting on Wednesday, during which the US President offered to provide Maximum height of 500m of BioNTech / Pfizer jab in developing countries.
At a vaccination group meeting at the Centers for Disease Control Wednesday, Natalie Thornburg, a CDC scientist, provided a note showing that although the number of antibodies decreases over time, cell memory remains intact.
The scientists also questioned whether the BioNTech / Pfizer jab should be approved in front of the Modern booster, which could lead to confusion if people would receive a third share from the same company with their first vaccination list.
The CDC team meets again on Thursday to discuss vaccine supplementation.
Recent cases of coronavirus
Follow FT’s description and report on the global epidemic and the rapidly changing economic crisis Pano.